Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

HIMS

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Free Float 0.21B
Short Int % Utilisation 34.06%

2.2 Growth

Metric Value
EV/EBITDA 96.03

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* -8.52%
Risk / Std Dev (Ann.)* 92.07%
1-Year Price Return* -38.83%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $28.15
52-Week Range $13.74 – $65.30
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $2.35B $1.48B
Net income Reported net income $128.37M $126.04M
Total assets Year-end reported balance $2.15B $707.54M
Shareholders’ equity Year-end reported balance $540.93M $476.72M
Net margin Net income ÷ revenue 5.47% 8.54%
Asset turnover Revenue ÷ total assets 1.0895x 2.0868x
Equity multiplier Total assets ÷ shareholders’ equity 3.9833x 1.4842x
ROE Net margin × asset turnover × equity multiplier 23.73% 26.44%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $2.35B
Prior annual revenue $1.48B
EBIT $105.61M
Tax rate 21.00%
NOPAT = EBIT × (1 − tax rate) $83.43M
Forecast start-growth basis 15.00%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $83.43M
Add: depreciation & amortisation $54.50M
Less: capital expenditure -$242.59M
Less/(add): working-capital cash-flow movement -$29.16M
Current unlevered FCFF -$133.82M

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 15.00% $95.95M $62.68M -$278.98M -$33.54M -$153.89M -$142.73M
2 11.88% $107.34M $70.12M -$251.61M -$37.52M -$111.67M -$89.10M
3 8.75% $116.74M $76.26M -$207.84M -$40.80M -$55.65M -$38.19M
4 5.62% $123.30M $80.55M -$150.04M -$43.10M $10.72M $6.33M
5 2.50% $126.38M $82.56M -$82.56M -$44.17M $82.21M $41.76M

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 2.42
Cost of equity 17.99%
Pre-tax cost of debt 7.71%
WACC 16.24%
WACC validation requires assumption review

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $613.08M
Implied terminal EV / EBITDA 2.53x
Terminal value as % of enterprise value 431.74%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF -$221.93M
Present value of terminal value $288.83M
Indicated enterprise value $66.90M
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $66.90M
Less: gross interest-bearing debt $1.12B
Add: cash and equivalents $577.49M
Add: affiliate investments $0.00
Less: minority interests $0.00
Indicated common equity value -$476.20M

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 258,230,547.00
Share-count basis reported diluted weighted-average shares
Current market price $27.87
DCF indicative value per share -$1.84
Indicative value vs. market price -106.62%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range review required
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration review required
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 1/4 evidenced checks
Lynch-inspired balance-and-growth checks 3/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:36:27.626438 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha 3.69% -25.85%
Adjusted R² 0.21 0.23
Annualised residual volatility 81.35% 79.98%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 1.76 (3.67) 1.07 (1.98)
Size (SMB) 1.70 (2.63) 1.45 (2.10)
Value (HML) -2.13 (-3.83) -1.72 (-2.54)
Profitability (RMW) NM -1.48 (-2.58)
Investment (CMA) NM -0.24 (-0.24)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

stock